Department of Gastroenterology and Hepatology/Digestive Endoscopy Medical Engineering Research Laboratory, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan, China.
Department of Gastroenterology, Armed Police Forces Hospital of Sichuan, Leshan, China.
Surg Endosc. 2024 Oct;38(10):5575-5583. doi: 10.1007/s00464-024-11124-y. Epub 2024 Aug 1.
The effect of tumor budding (TB) on the prognosis of patients with esophageal squamous cell carcinoma (ESCC) after endoscopic submucosal dissection (ESD) remains unclear. We evaluated the long-term outcomes of patients with superficial ESCC after ESD and the risk factors of TB for the long-term prognosis.
We conducted a retrospective study in a Chinese hospital. All patients with ESCC treated by ESD and reported TB were included consecutively. Comparative analyses were conducted in three parts: specimen analysis, follow-up analyses of unmatched patients, and propensity score-matched (PSM) patients. Cox proportional hazard regression models were constructed to identify risk factors for overall survival and recurrence-free survival (RFS).
A total of 437 patients were enrolled [154 TB and 283 no tumor budding (NTB)], and 258 patients (52 TB and 206 NTB) were included in the follow-up analysis. Results showed that the invasion depth, differentiation type, and positive vascular invasion (all p < 0.001) of the TB group were significantly different from the NTB group. The all-cause mortality and the median RFS time between the two groups were comparable. RFS rate at 5 years were 84.6% and 80.6%, respectively (p = 0.43). Cox analyses identified that having other cancers but not TB, as a risk factor independently associated with overall survival and RFS after ESD.
TB tends to be associated with invasion depth, differentiation type, and positive vascular invasion. However, it might not affect the long-term outcomes of patients with superficial ESCC after ESD when other high-risk factors are negative.
肿瘤芽(TB)对接受内镜黏膜下剥离术(ESD)治疗后的食管鳞状细胞癌(ESCC)患者预后的影响尚不清楚。我们评估了接受 ESD 治疗的浅表性 ESCC 患者的长期结局,并分析了 TB 对长期预后的风险因素。
我们在中国的一家医院进行了一项回顾性研究。所有接受 ESD 治疗且报告有 TB 的 ESCC 患者均连续纳入。进行了三个部分的对比分析:标本分析、未匹配患者的随访分析和倾向评分匹配(PSM)患者分析。构建 Cox 比例风险回归模型来识别总生存率和无复发生存率(RFS)的危险因素。
共纳入 437 例患者[154 例有 TB,283 例无 TB],258 例患者(52 例有 TB,206 例无 TB)纳入随访分析。结果显示,TB 组的浸润深度、分化类型和阳性脉管侵犯(均 p<0.001)与 NTB 组明显不同。两组之间的全因死亡率和中位 RFS 时间相当。两组 5 年 RFS 率分别为 84.6%和 80.6%(p=0.43)。Cox 分析确定其他癌症而非 TB 是 ESD 后总生存率和 RFS 的独立危险因素。
TB 往往与浸润深度、分化类型和阳性脉管侵犯相关。然而,当其他高危因素为阴性时,TB 可能不会影响接受 ESD 治疗的浅表性 ESCC 患者的长期结局。